FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017130249> ?p ?o ?g. }

• W2017130249 abstract "Plasminogen activator inhibitor 1 (PAI-1) overexpression is an important prognostic and predictive biomarker in human breast cancer. SERBP1, a protein that is supposed to regulate the stability of PAI-1 mRNA, may play a role in gynaecological cancers as well, since upregulation of SERBP1 was described in ovarian cancer recently. This is the first study to present a systematic characterisation of SERBP1 expression in human breast cancer and normal breast tissue at both the mRNA and the protein level.Using semiquantitative realtime PCR we analysed SERBP1 expression in different normal human tissues (n = 25), and in matched pairs of normal (n = 7) and cancerous breast tissues (n = 7). SERBP1 protein expression was analysed in two independent cohorts on tissue microarrays (TMAs), an initial evaluation set, consisting of 193 breast carcinomas and 48 normal breast tissues, and a second large validation set, consisting of 605 breast carcinomas. In addition, a collection of benign (n = 2) and malignant (n = 6) mammary cell lines as well as breast carcinoma lysates (n = 16) were investigated for SERBP1 expression by Western blot analysis. Furthermore, applying non-radioisotopic in situ hybridisation a subset of normal (n = 10) and cancerous (n = 10) breast tissue specimens from the initial TMA were analysed for SERBP1 mRNA expression.SERBP1 is not differentially expressed in breast carcinoma compared to normal breast tissue, both at the RNA and protein level. However, recurrence-free survival analysis showed a significant correlation (P = 0.008) between abundant SERBP1 expression in breast carcinoma and favourable prognosis. Interestingly, overall survival analysis also displayed a tendency (P = 0.09) towards favourable prognosis when SERBP1 was overexpressed in breast cancer.The RNA-binding protein SERBP1 is abundantly expressed in human breast cancer and may represent a novel breast tumour marker with prognostic significance. Its potential involvement in the plasminogen activator protease cascade warrants further investigation." @default.
• W2017130249 created "2016-06-24" @default.
• W2017130249 creator A5001964315 @default.
• W2017130249 creator A5002555374 @default.
• W2017130249 creator A5017728105 @default.
• W2017130249 creator A5021445780 @default.
• W2017130249 creator A5032577911 @default.
• W2017130249 creator A5037967462 @default.
• W2017130249 creator A5042448145 @default.
• W2017130249 creator A5044421523 @default.
• W2017130249 creator A5049556121 @default.
• W2017130249 creator A5049585448 @default.
• W2017130249 creator A5056731337 @default.
• W2017130249 creator A5058453547 @default.
• W2017130249 creator A5067050671 @default.
• W2017130249 date "2012-12-01" @default.
• W2017130249 modified "2023-10-04" @default.
• W2017130249 title "Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis" @default.
• W2017130249 cites W14437416 @default.
• W2017130249 cites W154425580 @default.
• W2017130249 cites W1595325564 @default.
• W2017130249 cites W17844780 @default.
• W2017130249 cites W1971695900 @default.
• W2017130249 cites W1981873412 @default.
• W2017130249 cites W1987163371 @default.
• W2017130249 cites W1990053396 @default.
• W2017130249 cites W1995171526 @default.
• W2017130249 cites W1996071034 @default.
• W2017130249 cites W2005113904 @default.
• W2017130249 cites W2010871781 @default.
• W2017130249 cites W2011108031 @default.
• W2017130249 cites W2036900122 @default.
• W2017130249 cites W2043824034 @default.
• W2017130249 cites W2053014622 @default.
• W2017130249 cites W2061019292 @default.
• W2017130249 cites W2070159701 @default.
• W2017130249 cites W2075486830 @default.
• W2017130249 cites W2085628794 @default.
• W2017130249 cites W2102934843 @default.
• W2017130249 cites W2117305280 @default.
• W2017130249 cites W2148313173 @default.
• W2017130249 cites W2152635438 @default.
• W2017130249 cites W2315527773 @default.
• W2017130249 cites W2405442768 @default.
• W2017130249 cites W4256508844 @default.
• W2017130249 cites W4319720718 @default.
• W2017130249 doi "https://doi.org/10.1186/1471-2407-12-597" @default.
• W2017130249 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3538721" @default.
• W2017130249 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23236990" @default.
• W2017130249 hasPublicationYear "2012" @default.
• W2017130249 type Work @default.
• W2017130249 sameAs 2017130249 @default.
• W2017130249 citedByCount "23" @default.
• W2017130249 countsByYear W20171302492013 @default.
• W2017130249 countsByYear W20171302492014 @default.
• W2017130249 countsByYear W20171302492015 @default.
• W2017130249 countsByYear W20171302492016 @default.
• W2017130249 countsByYear W20171302492017 @default.
• W2017130249 countsByYear W20171302492018 @default.
• W2017130249 countsByYear W20171302492019 @default.
• W2017130249 countsByYear W20171302492020 @default.
• W2017130249 countsByYear W20171302492021 @default.
• W2017130249 countsByYear W20171302492022 @default.
• W2017130249 crossrefType "journal-article" @default.
• W2017130249 hasAuthorship W2017130249A5001964315 @default.
• W2017130249 hasAuthorship W2017130249A5002555374 @default.
• W2017130249 hasAuthorship W2017130249A5017728105 @default.
• W2017130249 hasAuthorship W2017130249A5021445780 @default.
• W2017130249 hasAuthorship W2017130249A5032577911 @default.
• W2017130249 hasAuthorship W2017130249A5037967462 @default.
• W2017130249 hasAuthorship W2017130249A5042448145 @default.
• W2017130249 hasAuthorship W2017130249A5044421523 @default.
• W2017130249 hasAuthorship W2017130249A5049556121 @default.
• W2017130249 hasAuthorship W2017130249A5049585448 @default.
• W2017130249 hasAuthorship W2017130249A5056731337 @default.
• W2017130249 hasAuthorship W2017130249A5058453547 @default.
• W2017130249 hasAuthorship W2017130249A5067050671 @default.
• W2017130249 hasBestOaLocation W20171302491 @default.
• W2017130249 hasConcept C104317684 @default.
• W2017130249 hasConcept C105580179 @default.
• W2017130249 hasConcept C111683008 @default.
• W2017130249 hasConcept C118646709 @default.
• W2017130249 hasConcept C121608353 @default.
• W2017130249 hasConcept C126322002 @default.
• W2017130249 hasConcept C142724271 @default.
• W2017130249 hasConcept C143998085 @default.
• W2017130249 hasConcept C193270364 @default.
• W2017130249 hasConcept C204232928 @default.
• W2017130249 hasConcept C2779679481 @default.
• W2017130249 hasConcept C2780140570 @default.
• W2017130249 hasConcept C2780675426 @default.
• W2017130249 hasConcept C3018521938 @default.
• W2017130249 hasConcept C502942594 @default.
• W2017130249 hasConcept C530470458 @default.
• W2017130249 hasConcept C55493867 @default.
• W2017130249 hasConcept C71924100 @default.
• W2017130249 hasConcept C86803240 @default.
• W2017130249 hasConceptScore W2017130249C104317684 @default.
• W2017130249 hasConceptScore W2017130249C105580179 @default.
• W2017130249 hasConceptScore W2017130249C111683008 @default.

• next